Novel typhoid vaccine surpasses old ones | Science News


Support credible science journalism.

Subscribe to Science News today.


Novel typhoid vaccine surpasses old ones

2:20pm, April 25, 2001

Although many people in industrialized countries think of typhoid fever as a

scourge of bygone times, the disease strikes more than 16 million people worldwide

every year. Adults immunized with the best available vaccines still face a 30

percent risk of contracting typhoid if they come into contact with Salmonella

typhi, the bacterium that causes the disease. The vaccines impart even weaker

protection to young children.

A study of Vietnamese children 2 to 5 years old now provides the best showing ever

for a typhoid vaccine, says study coauthor Feng Ying C. Lin, a pediatrician at the

National Institutes of Child Health and Human Development (NICHD) in Bethesda, Md.

The new vaccine can slash typhoid risk after contact with the pathogen to less

than 10 percent.

Beginning in 1997, Lin and her colleagues gave 11,091 children living in a

This article is available only to subscribing members. Join the Society today or Log in.

Get Science News headlines by e-mail.

More from Science News